Amarantus Bioscience Holdings Inc (AMBS)

[Solantey]

Diolution wasn't an issue when there were high expectations that the company might receive an up-front cash payment from a partnership with Becton Dickinson to market LymPro which would have eliminated a need for more dilution. When Gerald stated there would be no near term partnership on LymPro and with subsequent developments there will obviously not be any commercialization of LymPro until some time in 2015 it became obvious that dilution would continue.

Did anyone think prior to Gerald's "foot in the mouth" statement that the company would have all one billion shares "in play" by the third quarter of 2014? Although it hasn't happened yet I expect it to.

When speculating as to why sentiment changes please be aware of the timeline of relevant events.

Just saying!!!